Fresenius is a German healthcare company that specializes in providing products and services for dialysis, hospital and outpatient medical care, and the production of essential pharmaceuticals. The company was founded in 1912 by Eduard Fresenius in Frankfurt, Germany. Initially, the company focused on manufacturing pharmaceuticals, but it expanded into dialysis equipment and services in the 1960s.

Fresenius operates its headquarters in Bad Homburg, Germany. The headquarters houses the management teams for all of the company's business segments and serves as a hub for strategic decision-making. The campus also includes research and development facilities, where the company develops new medical technologies and pharmaceutical products.

The main products and services offered by Fresenius include hemodialysis, peritoneal dialysis, and continuous renal replacement therapy equipment and supplies. The company also offers hospital equipment, such as infusion pumps, bloodlines, and other medical devices. In addition, Fresenius is a leading pharmaceutical company, producing generic drugs, infusion solutions, and clinical nutrition products.

On a global scale, Fresenius operates in over 100 countries through its various subsidiaries. Noteworthy subsidiaries include Fresenius Medical Care, the world's largest provider of dialysis products and services, and Fresenius Kabi, a leading pharmaceutical company. The company has also formed strategic partnerships and joint ventures with other healthcare companies to expand its market reach and capabilities.

Fresenius holds a strong market position, with its global sales reaching €36. 2 billion in 2020. Its dominance in the dialysis market, along with the diversification into other healthcare segments, has helped the company maintain a competitive edge.

Some of its major competitors include B. Braun, Baxter International, and DaVita. In recent years, Fresenius has focused on strategic acquisitions and partnerships to drive growth.

The company acquired NxStage Medical, a leading manufacturer of home hemodialysis machines, in 2018. This acquisition expanded Fresenius' presence in the home dialysis market. Additionally, Fresenius has been investing in research and development to develop innovative medical technologies and treatments.

As of the latest updates, Fresenius continues to be a global leader in the healthcare industry. The company remains committed to improving patient care and expanding its product and service offerings. With its strong market position, diverse portfolio, and ongoing growth initiatives, Fresenius is well-positioned for future success